Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Help North Carolina rebuild: WRAL's Hurricane Helene recovery fund raises $900K+
Recommended
Find a flu shot
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Illumina, Inc.
Illumina to Webcast Upcoming Investor Conference
July 28, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
July 22, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
July 13, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
June 01, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina To Webcast Upcoming Investor Conference
May 27, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development
May 17, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina To Webcast Upcoming Investor Conference
April 29, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
April 29, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
April 28, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina Reports Financial Results for First Quarter of Fiscal Year 2021
April 27, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
April 22, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
April 20, 2021
From
Illumina, Inc.
Via
Business Wire
Tickers
ILMN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.